CESCA THERAPEUTICS INC - 157131103

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q2 2014 · Q1 2014
Value (USD)
Total reported value ($000)
$4.566M
QoQ value delta ($000)
-$225K (-4.7%)
Implied price effect (QoQ)
-9.38%
Shares
Total shares
2,967,638
QoQ shares delta
+145,695 (+5.16%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Top holders (Q2 2014)

Top 25 only Full list
Partial Q2 2014 data: 6 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BlackRock Institutional Trust Company, N.A. 1,451 1,043,735 0.0%
SABBY MANAGEMENT, LLC 900 529,298 0.05%
VANGUARD GROUP INC 636 457,554 0.0%
Hudson Bay Capital Management LP 595 350,000 0.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 582 342,415 0.0%
GEODE CAPITAL MANAGEMENT, LLC 136 80,228 0.0%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 80 49,674 0.0%
NORTHERN TRUST CORP 49 28,672 0.0%
UBS AG 33 19,413 0.0%
Bank of New York Mellon Corp 25 14,934 0.0%
GUGGENHEIM CAPITAL LLC 21 12,491 0.0%
MORGAN STANLEY 19 11,510 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 14 10,000 0.0%
BLACKROCK ADVISORS LLC 8 5,823 0.0%
Tower Research Capital LLC 7 4,264 0.0%
BlackRock Investment Management, LLC 5 3,814 0.0%
BANK OF MONTREAL /CAN/ 4 2,500 0.0%
Clarkston Capital Partners LLC 1 1,250 0.0%
BANK OF AMERICA CORP /DE/ 0 62 0.0%
ROYAL BANK OF CANADA 0 1 0.0%